{"disease":{"id":"stage-iv-adrenocortical-carcinoma","name":"stage iv adrenocortical carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00003453","title":"Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Burzynski Research Institute","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}